Catalyst Wire Dossier Catalyst Wire Dossier

DIOVAN

valsartan · Novartis Pharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

51 regulatory and trial events tracked for DIOVAN, covering 2006-11-22 to 2021-07-22. Get the full timeline:

Most recent: FDA Approved: DIOVAN — Supplemental Application (Novartis Pharmaceuticals Corporation)

See pricing